Multifocal Well-Differentiated Small Intestinal Neuroendocrine Tumor Presenting as Partial Small Bowel Obstruction in an Elderly Female: A Case Report
This case report describes a 77-year-old female with multifocal small intestinal neuroendocrine tumors who experienced diagnostic delays due to missed biomarker screening, underwent complex surgical resections revealing discordant findings between advanced imaging and final pathology, and ultimately highlights the critical need for early biomarker utilization in patients with unexplained gastrointestinal symptoms.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Inside the human body, the small intestine is a long, winding tube responsible for absorbing nutrients. Occasionally, tiny, slow-growing tumors can form there from cells that normally help regulate digestion. These growths, known as neuroendocrine tumors, are rare and often hide in plain sight. Because they grow so slowly and cause vague symptoms like stomach discomfort or nausea, they are frequently missed for years. Doctors have blood and urine tests that can spot chemical clues left behind by these tumors, but these tools are not always used right away. When a tumor is finally found, it has often grown large enough to tangle the surrounding tissue or spread to nearby lymph nodes, making treatment much more difficult. Understanding how these tumors behave and how to catch them earlier is a critical challenge for modern medicine.
This story begins with a seventy-seven-year-old woman who had been suffering from persistent abdominal pain and unexplained weight loss for months. She had lost twenty pounds without trying, a significant warning sign that something was wrong. Her doctors ordered a scan of her abdomen, which revealed a solid mass in the tissue that holds the intestines in place. This mass had pulled the nearby loops of the small bowel together, creating a distinctive pattern on the image that looked like the spokes of a wheel. This pattern is a classic sign that a tumor has triggered a strong scarring reaction in the body, a process that often causes the bowel to kink and become partially blocked. Despite these clear signs, the medical team did not perform the specific blood and urine tests that could have confirmed the nature of the tumor before sending her to surgery.
The patient underwent her first operation, where surgeons removed a section of her small intestine along with the large, tangled mass. When the tissue was examined under a microscope, the diagnosis was confirmed: she had a well-differentiated neuroendocrine tumor. This type of tumor is considered low-grade, meaning the cells look very similar to normal cells and divide very slowly. However, the extent of the disease was surprisingly advanced. The tumor had grown through the outer wall of the intestine, invaded nearby blood vessels and nerves, and spread to three of the fourteen lymph nodes that were removed. One edge of the removed tissue still contained tumor cells, indicating that the surgery had not removed everything. The patient was left with a diagnosis that combined a slow-growing cell type with a dangerous, widespread location.
Following this surgery, the medical team used a specialized type of imaging scan that lights up tumor cells to see if any disease remained. This scan, which uses a radioactive tracer that attaches to specific proteins on the tumor surface, found a single bright spot in the tissue near the main artery that supplies blood to the intestines. This bright spot suggested that a piece of the tumor was still there. Because the location was so close to a major blood vessel, the decision was made to perform a second surgery to remove it. During this second operation, the surgeons carefully dissected the area and found a small nodule of tissue stuck directly to a branch of the superior mesenteric artery. To remove it safely, they had to cut the branch and repair it with a fine suture.
When this second piece of tissue was analyzed, the results were unexpected. Despite the bright signal on the scan, the tissue contained no cancer cells at all. Instead, it was made up entirely of scar tissue and chronic inflammation. This finding raises an important question for doctors: can the scarring reaction caused by the original tumor create a false signal on these advanced scans, making it look like cancer is still present when it is not? In this case, the bright spot was a ghost of the disease, a remnant of the body's healing process rather than a remaining threat. Because the second surgery removed all visible disease and the pathology showed no cancer, the patient was placed on a plan of active surveillance. This means she will be monitored closely with regular tests and scans, but she will not receive further treatment unless the disease returns.
The case highlights a missed opportunity in the patient's care. The specific blood and urine tests that could have identified the tumor earlier were not ordered before her first surgery. Had they been used, the diagnosis might have been made sooner, potentially before the tumor had spread to the lymph nodes or caused such extensive scarring. The story also illustrates a complex paradox: a tumor that looks very harmless under a microscope can still behave aggressively in the body, spreading widely and causing severe complications. Furthermore, the experience with the second surgery shows that even the most advanced imaging tools can sometimes be confused by the body's own healing scars. For patients with unexplained weight loss and long-term stomach issues, this case suggests that doctors should consider these specific tumor markers early in the diagnostic process to avoid delays and ensure the most accurate treatment plan.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.